Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POU class 2 homeobox associating factor 2 (POU2AF2, also known as C11orf53 or OCA-T1) is a transcriptional co-activator that plays a pivotal role in maintaining enhancer activity and chromatin accessibility, primarily through its partnership with the master transcription factor POU2F3[1][3][4]. POU2AF2 is essential for the maintenance and differentiation of tuft cells in various epithelial tissues, influencing gene expression by co-activating distal enhancer elements and interacting with chromatin remodeling complexes such as SWI/SNF[1][2][3]. Genetic depletion of POU2AF2 leads to altered transcriptional landscapes, chromatin structure changes, and can impair cell viability—particularly in tuft-cell-like small cell lung cancer, making it a candidate therapeutic target within this cancer subtype[1][3]. POU2AF2 does not function as a classical DNA-binding factor: it lacks direct chromatin recognition domains, instead it is recruited to chromatin by POU2F3 to facilitate open chromatin and regulate lineage-specific gene expression. Additionally, POU2AF2 is identified as a critical regulator for tuft cell-mediated immune responses in tissues such as the gut, highlighting its broader role in epithelial biology and immunity[4]. No direct drug interactions or approved therapeutics currently target POU2AF2, though its pathway is considered a potential intervention strategy for certain cancers[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POU class 2 homeobox associating factor 2 (POU2AF2).